Cargando…

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide

Previously, arsenic trioxide showed impressive regression rates of acute promyelocytic leukemia. Here, we investigated molecular determinants of sensitivity and resistance of cell lines of different tumor types towards arsenic trioxide. Arsenic trioxide was the most cytotoxic compound among 8 arseni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sertel, Serkan, Tome, Margaret, Briehl, Margaret M., Bauer, Judith, Hock, Kai, Plinkert, Peter K., Efferth, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349672/ https://www.ncbi.nlm.nih.gov/pubmed/22590507 http://dx.doi.org/10.1371/journal.pone.0035584

Ejemplares similares

Phytomedicine in Otorhinolaryngology and Pulmonology: Clinical Trials with Herbal Remedies
por: Moghadam, Koosha Ghazi, et al.
Publicado: (2012)

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
por: Sertel, Serkan, et al.
Publicado: (2010)

Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology
por: Dawood, Mona, et al.
Publicado: (2018)

Mitochondrial Adaptations to Oxidative Stress Confer Resistance to Apoptosis in Lymphoma Cells
por: Wilkinson, Sarah T., et al.
Publicado: (2012)

Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2015)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
por: Zhang, Yun-Kai, et al.
Publicado: (2017)

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2016)

Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells
por: Yang, C-H, et al.
Publicado: (1999)

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
por: Chau, David, et al.
Publicado: (2015)

PML-RARA mutations confer varying arsenic trioxide resistance
por: Bai, Dong-Mei, et al.
Publicado: (2016)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
por: Griffin, Robert J., et al.
Publicado: (2012)

Dual effects of arsenic trioxide on tumor cells and the potential underlying mechanisms
por: Zhang, Xiao, et al.
Publicado: (2018)

Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
por: Yu, Mengzhen, et al.
Publicado: (2022)

Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
por: Balasundaram, Nithya, et al.
Publicado: (2022)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Immunological consequences of arsenic trioxide-induced necrosis
por: Gavali, Shubhangi, et al.
Publicado: (2023)

TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
por: Wang, Haiwei, et al.
Publicado: (2022)

Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Medicine, Evidence-Based Complementary and Alternative
Publicado: (2021)

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress
por: Masciarelli, S, et al.
Publicado: (2018)

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019)

Resveratrol and Arsenic Trioxide Act Synergistically to Kill Tumor Cells In Vitro and In Vivo
por: Zhao, Xiao-Yan, et al.
Publicado: (2014)

Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines
por: Rangwala, Fatima, et al.
Publicado: (2012)

Oxidative stress induced by the chemotherapeutic agent arsenic trioxide
por: Varghese, Mathews V., et al.
Publicado: (2013)

A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014)

Modulation of Cellular Response to Arsenic Trioxide Toxicity by Resveratrol
por: Mondal, Bodhisattwa, et al.
Publicado: (2018)

On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)

Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma
por: Lu, Wei, et al.
Publicado: (2017)

Effect of arsenic trioxide on cervical cancer and its mechanisms
por: Zhang, Liping, et al.
Publicado: (2020)

QT Independent Ventricular Tachycardia Induced by Arsenic Trioxide
por: Zeitjian, Vicken, et al.
Publicado: (2019)

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
por: Zheng, Tongsen, et al.
Publicado: (2014)

Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells
por: Chiu, Hui-Wen, et al.
Publicado: (2012)

Zeolitic Imidazolate Framework‐8 as pH‐Sensitive Nanocarrier for “Arsenic Trioxide” Drug Delivery
por: Ettlinger, Romy, et al.
Publicado: (2019)

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening
por: Chen, Jun-Zhu, et al.
Publicado: (2023)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
por: Li, Jiabing, et al.
Publicado: (2023)

Arsenic speciation in saliva of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
por: Chen, Baowei, et al.
Publicado: (2013)

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
por: Lin, Tseng-Hsi, et al.
Publicado: (2008)

Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma
por: Feng, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6jmfcj4kgin50jchpp0bn37k8e